A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation

Nature Cell Biology

Volumn 3, Issue 3, 2001, Pages 267-275

  Selvarajan, Sushma ^a,b   Lund, Leif R ^b,c   Takeuchi, Toshihiko ^b   Craik, Charles S ^b   Werb, Zena ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c FINSEN LABORATORY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; LIPID; PLASMA KALLIKREIN; PLASMINOGEN; SERINE PROTEINASE INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL SHAPE; CELL STRAIN 3T3; CONTROLLED STUDY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; INVOLUTION; LIPID STORAGE; MAMMARY GLAND; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN DEFECT; STROMA CELL;

ADIPOCYTES; ANIMALS; AZO COMPOUNDS; BACTERIAL PROTEINS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; COAGULANTS; COLORING AGENTS; CULTURE MEDIA, SERUM-FREE; ESCHERICHIA COLI PROTEINS; FEMALE; FIBRONECTINS; HUMANS; IMMUNOHISTOCHEMISTRY; MAMMARY GLANDS, ANIMAL; MICE; PERIPLASMIC PROTEINS; PLASMA KALLIKREIN; PLASMIN; PLASMINOGEN; SERINE PROTEINASE INHIBITORS;

ANIMALIA;

EID: 0035095955     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/35060059     Document Type: Article

References (52)

1. Adipocyte differentiation and leptin expression
2. PPARγ: An essential regulator of adipogenesis and modulator of fat cell function
3. Control of adipocyte differentiation
4. Molecular regulation of adipocyte differentiation
5. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane
6. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin
7. IGFBP-3 proteolysis by plasmin, thrombin, serum: Heparin binding, IGF binding, and structure of fragments
8. Purification from Escherichia coli of a periplasmic protein that is a potent inhibitor of pancreatic proteases
9. Isolation of a high affinity inhibitor of urokinase-type plasminogen activator by phage display of ecotin
10. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells
11. A study of the adipose conversion of suspended 3T3 cells by using glycerophosphate dehydrogenase as differentiation marker
12. The plasminogen-plasmin system in malignancy
13. Plasminogen activators and plasminogen activator inhibitors: Biochemical aspects
14. Two distinct phase of apoptosis in mammary gland involution: Proteinase-independent and -dependent pathways
15. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction
16. Physiological consequences of loss of plasminogen activator gene function in mice
17. Ecotin is a potent inhibitor of the contact system proteases factor XIIa and plasma kallikrein
18. The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin
19. Plasminogen activators in dextran sulfate-activated euglobulin fractions: A molecular analysis of factor XII- and prekallikrein-dependent fibrinolysis
20. Activation of plasminogen by human plasma kallikrein
21. A comparison of the abilities of plasma kallikrein, beta-Factor XIIa, Factor XIa and urokinase to activate plasminogen
22. Heterogeneity of human prekallikrein deficiency (Fletcher trait): Evidence that five of 18 cases are positive for cross-reacting material
23. Kallikrein and kallikrein-like proteinases: Purification and determination by chromatographic and electrophoretic methods
24. Factor XIIa is a kinetically favorable plasminogen activator
25. Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: A mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis
26. High molecular weight kininogen peptides inhibit the formation of kallikrein on endothelial cell surfaces and subsequent urokinase- dependent plasmin formation
27. The ligand-binding domain of the cell surface receptor for urokinase- type plasminogen activator
28. Identification of the binding site for plasma prekallikrein in human high molecular weight kininogen. A region from residues 185 to 224 of the kininogen light chain retains full binding activity
29. Binding of high molecular weight kininogen to endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor
30. Plasminogen activators, tissue degradation, and cancer
31. Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice
32. PAI-1, obesity, insulin resistance and risk of cardiovascular events
33. Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide
34. Regulation of cell adhesion by PAI-1
35. Regulation of collagen gene expression in 3T3-L1 cells. Effects of adipocyte differentiation and tumor necrosis factor alpha
36. TGF beta 1 prevents the down-regulation of type I procollagen, fibronectin, and TGP beta 1 gene expression associated with 3T3-L1 pre-adipocyte differentiation
37. Effects of cytochalasin B and colchicine on attachment of a major surface protein of fibroblasts
38. Heparan sulfate chains from glypican and syndecans bind the Hep II domain of fibronectin similarly despite minor structural differences
39. Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice
40. Inhibition of adipogenesis by Wnt signaling
41. Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes
42. Impaired adipogenesis in insulin-like growth factor binding protein-1 transgenic mice
43. Plasmin degradation of insulin-like growth factor-binding protein-5 (IGFBP-5): Regulation by IGFBP-5-(201-218)
44. Insulin-like growth factor-binding protein-5 is cleaved by physiological concentrations of thrombin
45. Stromelysin-1 regulates adipogenesis during mammary gland involution
46. Lactational development and involution of the mammary gland requires plasminogen
47. Expression of specific mRNAs during adipose differentiation: Identification of an mRNA encoding a homologue of myelin P2 protein
48. Plasminogen: Purification from human plasma by affinity chromatography
49. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O
50. Growth hormone and erythropoietin differentially activate DNA-binding proteins by tyrosine phosphorylation
51. Proteinases of the mammary gland: Developmental regulation in vivo and vectorial secretion in culture